BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26944323)

  • 1. Phosphodiesterase inhibitor KMUP-3 displays cardioprotection via protein kinase G and increases cardiac output via G-protein-coupled receptor agonist activity and Ca(2+) sensitization.
    Liu CP; Yeh JL; Liou SF; Wu BN; Chen IJ
    Kaohsiung J Med Sci; 2016 Feb; 32(2):55-67. PubMed ID: 26944323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A xanthine-based epithelium-dependent airway relaxant KMUP-3 (7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine) increases respiratory performance and protects against tumor necrosis factor-alpha-induced tracheal contraction, involving nitric oxide release and expression of cGMP and protein kinase G.
    Lin RJ; Wu BN; Lo YC; An LM; Dai ZK; Lin YT; Tang CS; Chen IJ
    J Pharmacol Exp Ther; 2006 Feb; 316(2):709-17. PubMed ID: 16234412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KMUP-1, a xanthine derivative, induces relaxation of guinea-pig isolated trachea: the role of the epithelium, cyclic nucleotides and K+ channels.
    Wu BN; Lin RJ; Lo YC; Shen KP; Wang CC; Lin YT; Chen IJ
    Br J Pharmacol; 2004 Aug; 142(7):1105-14. PubMed ID: 15237094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of proinflammatory tumor necrosis factor-{alpha}-induced inducible nitric-oxide synthase by xanthine-based 7-[2-[4-(2-chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in rat trachea: The involvement of soluble guanylate cyclase and protein kinase G.
    Wu BN; Chen CW; Liou SF; Yeh JL; Chung HH; Chen IJ
    Mol Pharmacol; 2006 Sep; 70(3):977-85. PubMed ID: 16754782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
    Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
    Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway participates in the antiallodynic effect of spinal gabapentin.
    Mixcoatl-Zecuatl T; Flores-Murrieta FJ; Granados-Soto V
    Eur J Pharmacol; 2006 Feb; 531(1-3):87-95. PubMed ID: 16438951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthine-based KMUP-1 improves HDL via PPARγ/SR-B1, LDL via LDLRs, and HSL via PKA/PKG for hepatic fat loss.
    Kuo KK; Wu BN; Liu CP; Yang TY; Kao LP; Wu JR; Lai WT; Chen IJ
    J Lipid Res; 2015 Nov; 56(11):2070-84. PubMed ID: 26351364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic guanosine monophosphate-enhancing reduces androgenic extracellular regulated protein kinases-phosphorylation/Rho kinase II-activation in benign prostate hyperplasia.
    Liu CM; Fan YC; Lo YC; Wu BN; Yeh JL; Chen IJ
    Int J Urol; 2014 Jan; 21(1):87-92. PubMed ID: 23692571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cGMP-enhancing- and alpha1A/alpha1D-adrenoceptor blockade-derived inhibition of Rho-kinase by KMUP-1 provides optimal prostate relaxation and epithelial cell anti-proliferation efficacy.
    Liu CM; Lo YC; Wu BN; Wu WJ; Chou YH; Huang CH; An LM; Chen IJ
    Prostate; 2007 Sep; 67(13):1397-410. PubMed ID: 17639498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of uridine 5'-triphosphate-suppressed delayed rectifying K
    Dai ZK; Kao CL; Hsieh SL; Chen IJ; Wu BN
    Kaohsiung J Med Sci; 2016 Dec; 32(12):607-613. PubMed ID: 27914611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adenylate and guanylate cyclases in beta1-, beta2-, and beta3-adrenoceptor-mediated relaxation of internal anal sphincter smooth muscle.
    Li F; De Godoy M; Rattan S
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1111-20. PubMed ID: 14711933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
    Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
    J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KMUP-1 inhibits H441 lung epithelial cell growth, migration and proinflammation via increased NO/CGMP and inhibited RHO kinase/VEGF signaling pathways.
    Wu BN; Chen HY; Liu CP; Hsu LY; Chen IJ
    Int J Immunopathol Pharmacol; 2011; 24(4):925-39. PubMed ID: 22230399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway in the antihyperalgesic effects of bovine lactoferrin in a model of neuropathic pain.
    Wang J; Zhang LC; Lv YW; Ji Y; Yan XJ; Xue JP
    Brain Res; 2008 May; 1209():1-7. PubMed ID: 18406400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aortic smooth muscle relaxants KMUP-3 and KMUP-4, two nitrophenylpiperazine derivatives of xanthine, display cGMP-enhancing activity: roles of endothelium, phosphodiesterase, and K+ channel.
    Wu BN; Chen IC; Lin RJ; Chiu CC; An LM; Chen IJ
    J Cardiovasc Pharmacol; 2005 Nov; 46(5):600-8. PubMed ID: 16220066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide regulates AKT phosphorylation and nuclear translocation in cultured retinal cells.
    Mejía-García TA; Portugal CC; Encarnação TG; Prado MA; Paes-de-Carvalho R
    Cell Signal; 2013 Dec; 25(12):2424-39. PubMed ID: 23958999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible participation of the nitric oxide-cyclic GMP-protein kinase G-K+ channels pathway in the peripheral antinociception of melatonin.
    Hernández-Pacheco A; Araiza-Saldaña CI; Granados-Soto V; Mixcoatl-Zecuatl T
    Eur J Pharmacol; 2008 Oct; 596(1-3):70-6. PubMed ID: 18755181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KMUP-1 inhibits pulmonary artery proliferation by targeting serotonin receptors/transporter and NO synthase, inactivating RhoA and suppressing AKT/ERK phosphorylation.
    Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
    Vascul Pharmacol; 2010; 53(5-6):239-49. PubMed ID: 20870034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KMUP-1 Ameliorates Ischemia-Induced Cardiomyocyte Apoptosis through the NO⁻cGMP⁻MAPK Signaling Pathways.
    Lee ML; Sulistyowati E; Hsu JH; Huang BY; Dai ZK; Wu BN; Chao YY; Yeh JL
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30965668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.